Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$121.0 - $257.67 $116,281 - $247,620
-961 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$112.98 - $319.93 $28,357 - $80,302
-251 Reduced 20.71%
961 $166,000
Q4 2020

Jan 13, 2021

BUY
$78.74 - $139.5 $78,503 - $139,081
997 Added 463.72%
1,212 $135,000
Q3 2020

Nov 12, 2020

SELL
$79.44 - $178.51 $158 - $357
-2 Reduced 0.92%
215 $23,000
Q2 2020

Aug 13, 2020

BUY
$13.86 - $83.61 $1,621 - $9,782
117 Added 117.0%
217 $18,000
Q1 2020

May 12, 2020

BUY
$3.93 - $16.0 $393 - $1,600
100 New
100 $1,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $674M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.